ArticleAmerican health & drug benefits2019

Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States.

Michael C Runken et al.PubMed ↗Full text ↗

No numbers read from the abstract.